Results 61 to 70 of about 7,470 (208)

85 Antimuscarinic Activities of Hycanthone Analogs: Possible Relationship with Animal Toxicity

open access: yes, 2020
The antimuscarinic activity of hycanthone and five antischistosomal analogs was determined in three biological assays of cholinergic systems.
Richard K Gordon, Peter K Chiang
core  

Antimuscarinic activity in a series of 2-substituted 1,3-dioxolanes

open access: yes, 1995
The synthesis and antimuscarinic activity on M1, M2 and M3 tissues of a series of 2-aryl and 2-alkyl-4-dimethylaminomethyl-1,3-dioxolane methiodide (3ac-3d) and their corresponding tertiary amines (4ac-4d) are described.
Meloni M. T.   +4 more
core   +1 more source

Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
This review charts the evolution of cholinergic therapies for neurodegenerative diseases—from classical acetylcholinesterase inhibitors (AChEIs) providing symptomatic relief to precision multi‐target drugs and neuromodulation (VNS, DBS, NIBS) that restore dysfunctional circuits. Emerging gene therapy, cell regeneration, and advanced cholinergic imaging
Lei Lei   +4 more
wiley   +1 more source

Postmenopausal overactive bladder

open access: yesMenopause Review, 2014
Bladder storage symptoms have a severe impact on many areas as regards the quality of life including health-related, social, psychological and working functions.
Jacek Tomaszewski
doaj   +1 more source

Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder

open access: yes, 2015
Objectives: Incidences of overactive bladder (OAB) and cognitive dysfunction increase with aging. Treatment of OAB with antimuscarinic agents may result in cognitive decline, especially in patients with Alzheimer's disease (AD).
ERGEN, ALİ   +12 more
core   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 9, Page 2081-2092, September 2026.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Seizures triggered by food intake in antimuscarinic-treated fasted animals: Evaluation of the experimental findings in terms of similarities to eating-triggered epilepsy

open access: yes, 2021
P>Food intake triggers convulsions in fasted mice and rats treated with antimuscarinic drugs, scopolamine or atropine. Bearing some similarities in triggering factor and manifestations of the seizures in patients with eating-evoked epilepsy, seizures in ...
Enginar, Nurhan, Nurten, Asiye
core   +1 more source

The Neurovascular Niche: A Gathering Venue for Neuroinflammation and Remyelination in Multiple Sclerosis

open access: yesActa Physiologica, Volume 242, Issue 9, September 2026.
ABSTRACT In the central nervous system (CNS), the tissue microenvironment is continuously monitored and regulated to secure the unobstructed function of neurons and of their networks. This is a key function of the neurovascular niche (NVN), which is the interface between the cells of the nervous tissue and the cells and the content of blood vessels. It
Ilias Kazanis   +4 more
wiley   +1 more source

The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder

open access: yesJournal of Pharmacological Sciences, 2010
We have reviewed the binding of antimuscarinic agents, used to treat urinary dysfunction in patients with overactive bladder, to muscarinic receptors in target and non-target tissues in vivo.
Akira Yoshida   +5 more
doaj   +1 more source

Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease

open access: yesDrug Design, Development and Therapy, 2017
Pierachille Santus,1 Dejan Radovanovic,1 Andrea Cristiano,1 Vincenzo Valenti,2 Maurizio Rizzi1 1Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Division of Respiratory Diseases, “L.
Santus P   +4 more
doaj  

Home - About - Disclaimer - Privacy